Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.

A fusion complementary DNA in the T cell line HSB-2 elucidates a provocative mechanism for the disruption of the putative hematopoietic transcription factor SCL. The fusion cDNA results from an interstitial deletion between a previously unknown locus, SIL (SCL interrupting locus), and the 5' untranslated region of SCL. Similar to 1;14 translocations, this deletion disrupts the SCL 5' regulatory region. This event is probably mediated by V-(D)-J recombinase activity, although neither locus is an immunoglobulin or a T cell receptor. Two other T cell lines, CEM and RPMI 8402, have essentially identical deletions. Thus, in lymphocytes, growth-affecting genes other than immune receptors risk rearrangements.

[1]  D. Lockshon,et al.  MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Stern,et al.  Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes , 1990, The Journal of experimental medicine.

[3]  H. Weintraub,et al.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation , 1990, Cell.

[4]  R. Berger,et al.  Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T‐cell leukemias , 1990, Genes, chromosomes & cancer.

[5]  David Baltimore,et al.  The V(D)J recombination activating gene, RAG-1 , 1989, Cell.

[6]  T. Waldmann,et al.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Sklar,et al.  T cell receptor gene trans-rearrangements: chimeric gamma-delta genes in normal lymphoid tissues. , 1989, Science.

[8]  D. Baltimore,et al.  Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription , 1989, Cell.

[9]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[10]  P. Nowell,et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[12]  T. Waldmann,et al.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Bradley,et al.  High-frequency deletion event ataprt locus of CHO cells: Detection and characterization of endpoints , 1989, Somatic cell and molecular genetics.

[14]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Lieber,et al.  Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[17]  F. Alt,et al.  Development of the primary antibody repertoire. , 1987, Science.

[18]  T. Rabbitts,et al.  The mechanism of chromosome 14 inversion in a human T cell lymphoma , 1987, Cell.

[19]  C. Croce,et al.  The role of chromosomal translocations in B- and T-cell neoplasia. , 1987, Annual review of immunology.

[20]  M. Raffeld,et al.  3A1 (CD7) expression precedes T beta gene rearrangements in precursor T (lymphoblastic) neoplasms. , 1986, Blood.

[21]  C. Denny,et al.  A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci , 1986, Nature.

[22]  F. Alt,et al.  Regulation of the assembly and expression of variable-region genes. , 1986, Annual review of immunology.

[23]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[24]  S. Korsmeyer,et al.  Translocations that highlight chromosomal regions of differentiated activity. , 1985, Cancer genetics and cytogenetics.

[25]  F. Alt,et al.  Developmentally controlled and tissue-specific expression of unrearranged VH gene segments , 1985, Cell.

[26]  F. Hecht,et al.  Common region on chromosome 14 in T-cell leukemia and lymphoma. , 1984, Science.

[27]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[28]  W. D. Peterson,et al.  Identification of T cell lymphoma tumor antigens on human T cell lines , 1976, American journal of hematology.

[29]  G. Moore,et al.  Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. , 1974, Journal of the National Cancer Institute.

[30]  H. Lazarus,et al.  The question of stemlines in human acute leukemia. Comparison of cells isolated in vitro and in vivo from a patient with acute lymphoblastic leukemia. , 1970, Experimental cell research.

[31]  B. Davis,et al.  Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2. , 1968, Cancer research.

[32]  S Farber,et al.  Cytogenetic analysis of human lymphoblasts in continuous culture. , 1965, Experimental cell research.

[33]  H. Lazarus,et al.  Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia , 1965, Cancer.